Drug profile · INN
cefditoren pivoxil
SPECTRACEF
cefditoren pivoxil (SPECTRACEF) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — cefditoren pivoxil
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
cefditoren pivoxil (SPECTRACEF) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cefditoren pivoxil?
cefditoren pivoxil (SPECTRACEF) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cefditoren pivoxil?
SPECTRACEF is a marketed brand name for cefditoren pivoxil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefditoren pivoxil?
cefditoren pivoxil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.